Search

Your search keyword '"Borsche, Max"' showing total 173 results

Search Constraints

Start Over You searched for: Author "Borsche, Max" Remove constraint Author: "Borsche, Max"
173 results on '"Borsche, Max"'

Search Results

3. Genotype–phenotype correlation in PRKN-associated Parkinson’s disease

5. Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project

10. Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study – a prospective population-based cohort study

12. α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification Assay

13. RFC1 and FGF14 Repeat Expansions in Serbian Patients with Cerebellar Ataxia

14. The role of dopaminergic medication, lipid, and endocannabinoid pathway alterations in idiopathic andPRKN/PINK1-mediated Parkinson’s disease – a large-scale targeted metabolomics study

18. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

20. Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project

21. Immune correlates against SARS-CoV-2 infection – results of population and hospital-based studies in the IMMUNEBRIDGE project in Germany, 2022

24. POLG2-Linked Mitochondrial Disease: Functional Insights from New Mutation Carriers and Review of the Literature

29. Estimates of protection against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season - the IMMUNEBRIDGE project

31. Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson's disease.

32. Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson’s disease

33. Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1- and PRKN-linked Parkinson's disease 2022.05.17.22275087

34. Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1- and PRKN-linked Parkinson’s disease

36. One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk

37. Additional file 1 of Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study – a prospective population-based cohort study

39. Eosinophils Suppress the Migration of T Cells Into the Brain of Plasmodium berghei-Infected Ifnar1-/- Mice and Protect Them From Experimental Cerebral Malaria

41. Frequency of Heterozygous Parkin (PRKN) Variants and Penetrance of Parkinson's Disease Risk Markers in the Population-Based CHRIS Cohort

42. Predictive modeling of spread in adult‐onset isolated dystonia: Key properties and effect of tremor inclusion

43. A Multi‐center Genome‐wide Association Study of Cervical Dystonia

45. Cohort-based surveillance of SARS-CoV2 transmission mirrors infection rates at the population level: a one-year longitudinal study

48. Metabolic markers distinguish COVID-19 from other intensive care patients and show potential to stratify for disease risk

49. Spreading of SARS-CoV-2 Among Adult Asylum Seekers in Refugee Shelters in Germany

50. Parkin Deficiency Appears Not to Be Associated with Cardiac Damage in Parkinson's Disease

Catalog

Books, media, physical & digital resources